Tomoki Kuge

565 total citations
31 papers, 164 citations indexed

About

Tomoki Kuge is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Infectious Diseases. According to data from OpenAlex, Tomoki Kuge has authored 31 papers receiving a total of 164 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 10 papers in Epidemiology and 8 papers in Infectious Diseases. Recurrent topics in Tomoki Kuge's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers), Mycobacterium research and diagnosis (7 papers) and Tuberculosis Research and Epidemiology (5 papers). Tomoki Kuge is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers), Mycobacterium research and diagnosis (7 papers) and Tuberculosis Research and Epidemiology (5 papers). Tomoki Kuge collaborates with scholars based in Japan, United States and France. Tomoki Kuge's co-authors include Yuji Yamamoto, Kazuyuki Tsujino, Keisuke Miki, Hiroshi Kida, Takanori Matsuki, Mari Miki, Atsushi Kumanogoh, Yoshito Takeda, Haruhiko Hirata and Kiyoharu Fukushima and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and European Journal of Cancer.

In The Last Decade

Tomoki Kuge

28 papers receiving 162 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tomoki Kuge Japan	8	94	70	45	28	23	31	164
Melanie Lavender Australia	8	79 0.8×	91 1.3×	65 1.4×	13 0.5×	28 1.2×	21	194
Hatice Türker Türkiye	8	135 1.4×	56 0.8×	35 0.8×	34 1.2×	61 2.7×	29	229
Aravind Ponnuswamy United Kingdom	4	90 1.0×	26 0.4×	24 0.5×	7 0.3×	8 0.3×	6	138
Stefano Greco Italy	5	155 1.6×	42 0.6×	72 1.6×	52 1.9×	61 2.7×	17	262
Beata Klincewicz Poland	7	76 0.8×	50 0.7×	19 0.4×	22 0.8×	54 2.3×	9	206
Yohei Ogata Japan	8	150 1.6×	31 0.4×	18 0.4×	29 1.0×	250 10.9×	30	303
Bianca Harris United States	5	74 0.8×	56 0.8×	49 1.1×	44 1.6×	18 0.8×	8	188
Yoichi Nishigaki Japan	8	21 0.2×	137 2.0×	42 0.9×	23 0.8×	64 2.8×	19	272
Jessica Harris United States	6	47 0.5×	37 0.5×	9 0.2×	78 2.8×	58 2.5×	12	176
Gönül Çaltepe Türkiye	9	38 0.4×	70 1.0×	17 0.4×	19 0.7×	83 3.6×	32	177

Countries citing papers authored by Tomoki Kuge

Since Specialization

Citations

This map shows the geographic impact of Tomoki Kuge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoki Kuge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoki Kuge more than expected).

Fields of papers citing papers by Tomoki Kuge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoki Kuge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoki Kuge. The network helps show where Tomoki Kuge may publish in the future.

Co-authorship network of co-authors of Tomoki Kuge

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoki Kuge. A scholar is included among the top collaborators of Tomoki Kuge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoki Kuge. Tomoki Kuge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Matsumoto, Kinnosuke, Akihiro Tamiya, Motohiro Tamiya, et al.. (2025). Timing of first pembrolizumab infusion and long-term outcomes in non-small cell lung cancer: A retrospective multicenter study. European Journal of Cancer. 228. 115748–115748.

Matsumoto, Kinnosuke, Yuji Yamamoto, Takayuki Shiroyama, et al.. (2024). Risk Stratification According to Baseline and Early Change in Neutrophil-to-Lymphocyte Ratio in Advanced Non-Small Cell Lung Cancer Treated with Chemoimmunotherapy: A Multicenter Real-World Study. Targeted Oncology. 19(5). 757–767.

Kuge, Tomoki, Takayuki Shiroyama, Akihiro Tamiya, et al.. (2023). Impact of Lymphopenia Recovery After Chemoradiotherapy on Durvalumab Consolidation Therapy in Stage III NSCLC. JTO Clinical and Research Reports. 4(5). 100505–100505. 2 indexed citations

Komukai, Sho, Tomoaki Hoshino, Kentaro Masuhiro, et al.. (2023). Identifying phenotypes in interstitial lung disease using group-based trajectory modelling. The International Journal of Tuberculosis and Lung Disease. 27(4). 332–334.

Kinehara, Yuhei, Takayuki Shiroyama, Akihiro Tamiya, et al.. (2023). Pneumonitis During Durvalumab Consolidation Therapy Affects Survival in Stage III NSCLC. JTO Clinical and Research Reports. 4(11). 100586–100586. 2 indexed citations

Yamamoto, Yuji, Takayuki Shiroyama, Haruhiko Hirata, et al.. (2023). Secondary subcutaneous abscess due to mixed infections by Peptoniphilus olsenii and Gleimia europaea after COVID ‐19. SHILAP Revista de lepidopterología. 11(1). e6844–e6844. 3 indexed citations

Yamamoto, Yuji, Haruhiko Hirata, Takayuki Shiroyama, et al.. (2022). Respiratory Impedance is Associated with Ventilation and Diffusing Capacity in Patients with Idiopathic Pulmonary Fibrosis Combined with Emphysema. International Journal of COPD. Volume 17. 1495–1506. 3 indexed citations

Matsumoto, Kinnosuke, Haruhiko Hirata, Takayuki Shiroyama, et al.. (2022). A case of synchronous triple autoimmune disorders secondary to thymoma: Pure red cell aplasia, Good's syndrome, and thymoma-associated multi-organ autoimmunity. Respiratory Medicine Case Reports. 36. 101619–101619. 2 indexed citations

Matsumoto, Kinnosuke, Takayuki Shiroyama, Tomoki Kuge, et al.. (2022). Impact of treatment line on risks and benefits of immune checkpoint inhibitor in patients with advanced non-small cell lung cancer and interstitial lung disease: a systematic review and meta-analysis of cohort studies. Translational Lung Cancer Research. 11(9). 1835–1846. 5 indexed citations

10.

Amiya, Saori, Kinnosuke Matsumoto, Makoto Yamamoto, et al.. (2022). Case report: Acute exacerbation of interstitial pneumonia related to messenger RNA COVID-19 vaccination. International Journal of Infectious Diseases. 116. 255–257. 11 indexed citations

11.

Matsumoto, Kinnosuke, Takayuki Shiroyama, Tomoki Kuge, et al.. (2021). Impact of treatment timing and sequence of immune checkpoint inhibitors and anti-angiogenic agents for advanced non-small cell lung cancer: A systematic review and meta-analysis. Lung Cancer. 162. 175–184. 11 indexed citations

12.

Fukushima, Kiyoharu, Seigo Kitada, Sho Komukai, et al.. (2021). First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease. Scientific Reports. 11(1). 1178–1178. 18 indexed citations

13.

Miki, Mari, Kazuyuki Tsujino, Takahiro Kawasaki, et al.. (2021). Pulmonary eosinophilia may indicate onset stage of allergic bronchopulmonary aspergillosis. Allergy Asthma and Clinical Immunology. 17(1). 118–118. 2 indexed citations

14.

Miki, Keisuke, Kazuyuki Tsujino, Ryoji Maekura, et al.. (2021). Oxygen Extraction Based on Inspiratory and Expiratory Gas Analysis Identifies Ventilatory Inefficiency in Chronic Obstructive Pulmonary Disease. Frontiers in Physiology. 12. 703977–703977. 4 indexed citations

15.

Niitsu, Takayuki, Tomoki Kuge, Kiyoharu Fukushima, et al.. (2021). Pleural Effusion Caused by Mycolicibacterium mageritense in an Immunocompetent Host: A Case Report. Frontiers in Medicine. 8. 797171–797171. 3 indexed citations

16.

Hara, Reina, Seigo Kitada, Tomoki Kuge, et al.. (2020). Diagnostic Validity of Gastric Aspirate Culture in Nontuberculous Mycobacterial Pulmonary Disease. Annals of the American Thoracic Society. 17(12). 1536–1541. 2 indexed citations

17.

Yamamoto, Yuji, Kazuyuki Tsujino, Tomoki Kuge, et al.. (2020). Pleuroparenchymal fibroelastosis inMycobacterium aviumcomplex pulmonary disease: clinical characteristics and prognostic impact. ERJ Open Research. 7(1). 765–2020. 10 indexed citations

18.

Yamamoto, Yuji, Keisuke Miki, Kazuyuki Tsujino, et al.. (2020). Evaluation of disease severity in bronchiectasis using impulse oscillometry. ERJ Open Research. 6(4). 53–2020. 8 indexed citations

19.

Kuge, Tomoki, Kiyoharu Fukushima, Yuki Matsumoto, et al.. (2020). Pulmonary disease caused by a newly identified mycobacterium: Mycolicibacterium toneyamachuris: a case report. BMC Infectious Diseases. 20(1). 888–888. 3 indexed citations

20.

Yamamoto, Yuji, Keisuke Miki, Kazuyuki Tsujino, et al.. (2020). Oscillometry and computed tomography findings in patients with idiopathic pulmonary fibrosis. ERJ Open Research. 6(4). 391–2020. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact